Whitehawk Therapeutics, Inc. revenue breakdown overview

Whitehawk Therapeutics, Inc. revenue for the last year amounted to 25.98 M USD, the most of which — 25.98 M USD — came from its highest performing source at the moment, Proprietary Therapeutics, the year earlier bringing 24.35 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Whitehawk Therapeutics, Inc. 25.98 M USD, and the year before that — 24.35 M USD.